(2S)-2-AMINO-N-((10S,23S)-10-ETHYL-18-FLUORO-10-HYDROXY-19-METHYL-5,9-DIOXO-8-OXA-4,15-DIAZAHEXACYCLO(14.7.1.02,14.04,13.06,11.020,24)TETRACOSA-1,6(11),12,14,16,18,20(24)-HEPTAEN-23-YL)PROPANAMIDE
UNII B5S9NSA7R4
Substance Identification & Data
This profile provides standardized clinical and technical data for (2s)-2-amino-n-((10s,23s)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo(14.7.1.02,14.04,13.06,11.020,24)tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl)propanamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B5S9NSA7R4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3010918-42-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H27FN4O5 BCSZBBTYBFKJFC-BEMWVBDCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2s)-2-amino-n-((10s,23s)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo(14.7.1.02,14.04,13.06,11.020,24)tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl)propanamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.